1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Dengue Global Clinical Trials Review, H1, 2015

Dengue Global Clinical Trials Review, H1, 2015

  • April 2015
  • -
  • Global Data
  • -
  • 81 pages

Dengue Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Dengue Global Clinical Trials Review, H1, 2015" provides data on the Dengue clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dengue. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dengue. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Dengue Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Dengue 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Dengue to Infectious Disease Clinical Trials 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Dengue to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in E7 Countries 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Dengue Therapeutics Clinical Trials 25
Prominent Drugs 27
Latest Clinical Trials News on Dengue 28
Mar 16, 2015: First Patient Enrolled in Cerus TRUE Study With the American Red Cross to Address Chikungunya and Dengue Blood Safety Risks With Pathogen Reduced Platelets 28
Feb 02, 2015: Takeda Announces Discontinuation of Phase 2 Program for DTaP/sIPV Vaccine in Japan 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Sanofi 30
Clinical Trial Overview of Sanofi 30
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Takeda Pharmaceutical Company Limited 33
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33
Merck and Co., Inc. 34
Clinical Trial Overview of Merck and Co., Inc. 34
Globavir Biosciences, Inc. 35
Clinical Trial Overview of Globavir Biosciences, Inc. 35
Cerus Corporation 36
Clinical Trial Overview of Cerus Corporation 36
Acuvax Ltd 37
Clinical Trial Overview of Acuvax Ltd 37
Abivax S.A. 38
Clinical Trial Overview of Abivax S.A. 38
60 Degrees Pharmaceuticals LLC 39
Clinical Trial Overview of 60 Degrees Pharmaceuticals LLC 39
Clinical Trial Overview of Top Institutes / Government 40
The National Institute of Allergy and Infectious Diseases 40
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 40
U.S. Army Medical Research and Materiel Command 42
Clinical Trial Overview of U.S. Army Medical Research and Materiel Command 42
University of Oxford 43
Clinical Trial Overview of University of Oxford 43
Guangzhou Eighth People's Hospital 44
Clinical Trial Overview of Guangzhou Eighth People's Hospital 44
Guangzhou University of Traditional Chinese Medicine 45
Clinical Trial Overview of Guangzhou University of Traditional Chinese Medicine 45
London School of Hygiene and Tropical Medicine 46
Clinical Trial Overview of London School of Hygiene and Tropical Medicine 46
Mahidol University 47
Clinical Trial Overview of Mahidol University 47
Office of the Surgeon General of the Army, Department of Defense 48
Clinical Trial Overview of Office of the Surgeon General of the Army, Department of Defense 48
Postgraduate Institute of Medical Education and Research 49
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 49
Singapore General Hospital 50
Clinical Trial Overview of Singapore General Hospital 50
Five Key Clinical Profiles 51
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81

List of Tables
Dengue Therapeutics, Global, Clinical Trials by Region, 2015* 7
Dengue Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Dengue Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Dengue Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Dengue Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Dengue Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 12
Proportion of Dengue to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 13
Dengue Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Dengue to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 15
Dengue Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 16
Dengue Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17
Dengue Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Dengue Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Dengue Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Dengue Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Dengue Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Dengue Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Dengue Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Dengue Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Dengue Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 30
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 32
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 33
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 34
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Globavir Biosciences, Inc., 2015* 35
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Cerus Corporation, 2015* 36
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Acuvax Ltd, 2015* 37
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Abivax S.A., 2015* 38
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by 60 Degrees Pharmaceuticals LLC, 2015* 39
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 40
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2015* 42
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2015* 43
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangzhou Eighth People's Hospital, 2015* 44
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangzhou University of Traditional Chinese Medicine, 2015* 45
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene and Tropical Medicine, 2015* 46
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2015* 47
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Office of the Surgeon General of the Army, Department of Defense, 2015* 48
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2015* 49
Dengue Therapeutics Clinical Trials Market, Global, Clinical Trials by Singapore General Hospital, 2015* 50

List of Figures
Dengue Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Dengue Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Dengue Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Dengue Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Dengue Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Dengue Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 12
Proportion of Dengue to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 13
Dengue Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Dengue to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 15
Dengue Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 16
Dengue Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17
Dengue Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Dengue Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Dengue Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Dengue Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Dengue Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Dengue Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Dengue Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Dengue Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Dengue Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
GlobalData Methodology 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the Netherlands

  • January 2017
    5 pages
  • Therapy  

  • Netherlands  

View report >

Insulin Market and Diabetes Statistics in the US

  • January 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Diabetes Statistics

  • January 2017
    10 pages
  • Diabetes  

    Therapy  

View report >

Therapy Market

31 hours ago

Related Market Segments :

Therapy
Clinical Trial
Vaccine

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.